25
Orange Grove Bio (“OGB”) is a preclinical drug development platform focused on driving down the cost of drug discovery and advancing therapies into clinical trials.
They are partnered with leading universities to license transformational medicines. Orange Grove Bio and its university partners streamline the licensing process to speed up the development process to get drugs to market faster and to save time on-patent.
